Clinical Trials
2 trialsNCT02834052 2024-06-07
Pembrolizumab + Poly-ICLC in MRP Colon Cancer
Augusta University
Phase 1/2 Completed
NCT00553683 2014-01-14
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Rutgers, The State University of New Jersey
Phase 1/2 Unknown